跳至主要内容
临床试验/ACTRN12607000345482
ACTRN12607000345482已完成4 期

The potential of selenium supplements provided as selenium-enriched dairy protein or yeast selenium to improve selenium status

Professor Graeme Young MD, FRACP0 个研究点目标入组 20 人开始时间: 2007年6月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 ot stated(—)
性别
All

入选标准

  • Healthy, with no active bowel disease, orWith a previous history of adenoma removal >6 months ago, With plasma selenium at or below 100 µg/dL. (to ensure that people with a High background selenium status are not included in the study),

排除标准

  • Any allergy or intolerance to milk/dairy productsPlasma Se above the 95th percentile of the current population (i.e. >100µg/dL)Evidence of any active mucosal bowel disease, eg colitis, or of malabsorption.With no evidence of any other active clinical disease precluding participation in the study.

研究者

发起方
Professor Graeme Young MD, FRACP

相似试验

The potential of selenium supplements provided as... | 临床试验